Author:
Jones N. A.,Spina D.,Page C. P.
Publisher
Springer Berlin Heidelberg
Reference257 articles.
1. Alfonso, A., Estevez, M., Louzao, M. C., Vieytes, M. R., and Botana, L. M. Determination of phosphodiesterase activity in rat mast cells using the fluorescent cAMP analogue anthraniloyl cAMP. Cell Signal. 7 (5), 513–518. 1995
2. Aloui, R., Gormand, E, Prigent, A. E, PerrinFayolle, M., and Pacheco, Y. Increased respiratory burst and phosphodiesterase activity in alveolar eosinophils in chronic eosinophilic pneumonia. Eur.Respir.J. 9, 377–379. 1996
3. Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R., Shelton, E. R., and Conti, M. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE4D3. Mol.Pharmacol. 48 (4), 616–622. 1995
4. Alves, A. C., Pires, A. L., Lagente, V., Cordeiro, R. S., Martins, M. A., and Silva, P. M. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro. Mem.Inst.Oswaldo Cruz 92 Suppl 2, 201–204. 1997
5. Alves, A. C., Pires, A. L. A., Cruz, H. N., Serra, M. F., Diaz, B. L., Cordeiro, R. S. B., Lagente, V, Martins, M. A., and de Silva, P. M. R. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Eur.J.Pharmacol. 312, 89–96. 1996